Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis

被引:1
|
作者
Ichikawa, Satoshi [1 ]
Fukuhara, Noriko [1 ]
Watanabe, Shotaro [1 ]
Okitsu, Yoko [1 ]
Onodera, Koichi [1 ]
Onishi, Yasushi [1 ]
Harigae, Hideo [1 ]
机构
[1] Tohoku Univ Hosp, Dept Hematol & Rheumatol, 1-1 Seilyo Cho, Sendai, Miyagi 9808574, Japan
基金
日本学术振兴会;
关键词
Fusarium solani; Disseminated fusariosis; Cord blood transplantation; Acute myeloid leukemia; STEM-CELL TRANSPLANTATION; ENDOPHTHALMITIS; MALIGNANCY; INFECTION;
D O I
10.1016/j.jiac.2019.08.022
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fusariosis is a critical infectious complication that can develop in immunocompromised hosts, mainly under conditions of prolonged neutropenia, and is often disseminated and associated with a high mortality rate. Disseminated fusariosis developing during the course of hematopoietic stem cell transplantation (HSCT) is a critical condition, and there have been few reports of successful treatment of cases complicated with fusariosis before HSCT. Here, we present a case of acute myeloid leukemia (AML) with the development of fungal endophthalmitis during chemotherapy. Vitrectomy was performed and Fusarium solani infection was confirmed by vitreal culture. The infection was also disseminated to the lung, triceps, and spleen. The splenic lesions disappeared with the administration of antifungal agents, and residual lesions in the lung and triceps were surgically resected. After two courses of consolidation chemotherapy, the patient received cord blood transplantation (CBT) twice because of graft failure in the first transplantation. Antifungal agents were administered continuously during chemotherapy and transplantation. Although Fusarium sinusitis developed after neutrophil engraftment, it was well controlled by surgical resection. Thereafter, the patient has been well without recurrence of fusariosis for more than 2 years since transplantation. A combination of continuous administration of antifungal agents and vigorous surgical intervention may be important for management of disseminated fusariosis in the setting of HSCT. (c) 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:292 / 295
页数:4
相关论文
共 50 条
  • [31] Cytomegalovirus-associated granulomatous gastritis after cord blood transplantation for acute myeloid leukemia
    Fujishima, Naohito
    Hirokawa, Makoto
    Fujishima, Masumi
    Saitoh, Hirobumi
    Odashima, Masaru
    Nanjo, Hiroshi
    Sawada, Ken-ichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (04) : 362 - 363
  • [32] Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
    M. Oda
    K. Isoyama
    E. Ito
    M. Inoue
    M. Tsuchida
    H. Kigasawa
    K. Kato
    S. Kato
    International Journal of Hematology, 2009, 89 : 374 - 382
  • [33] Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
    Oda, M.
    Isoyama, K.
    Ito, E.
    Inoue, M.
    Tsuchida, M.
    Kigasawa, H.
    Kato, K.
    Kato, S.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 374 - 382
  • [34] LONG-TERM SURVIVAL IN ACUTE LEUKEMIA IN CHILDHOOD
    WILLIAMS, K
    SHORE, N
    HAMMOND, D
    HYMAN, C
    HIGGINS, G
    ORTEGA, J
    KARON, M
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 973 - &
  • [35] Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients
    Specchia, Giorgina
    Pastore, Domenico
    Mestice, Anna
    Liso, Arcangelo
    Carluccio, Paola
    Leo, Manuela
    Casanova, Margherita
    Sibilla, Silvia
    Giannoccaro, Margherita
    Liso, Vincenzo
    ACTA HAEMATOLOGICA, 2006, 116 (04) : 229 - 237
  • [36] Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
    Arnold, Renate
    Hemmati, Philipp
    le Coutre, Philipp
    Lam Vuong
    Jehn, Christian
    Ostendorf, Benjamin
    Na, Il-Kang
    Penack, Olaf
    Doerken, Bernd
    Terwey, Theis
    Massenkeil, Gero
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S222 - S223
  • [37] Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
    Flasshove, M
    Meusers, P
    Schütte, J
    Noppeney, R
    Beelen, DW
    Sohrab, S
    Roggenbuck, U
    Kemmeries, G
    Brittinger, G
    Seeber, S
    Scheulen, ME
    ANNALS OF HEMATOLOGY, 2000, 79 (10) : 533 - 542
  • [38] Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
    M. Flasshove
    P. Meusers
    J. Schütte
    R. Noppeney
    D. W. Beelen
    S. Sohrab
    U. Roggenbuck
    G. Kemmeries
    G. Brittinger
    S. Seeber
    M. E. Scheulen
    Annals of Hematology, 2000, 79 : 533 - 542
  • [39] Long-term survival in acute myeloid leukemia - The Eastern Cooperative Oncology Group experience
    Bennett, JM
    Young, ML
    Andersen, JW
    Cassileth, PA
    Tallman, MS
    Paietta, E
    Wiernik, PH
    Rowe, JM
    CANCER, 1997, 80 (11) : 2205 - 2209
  • [40] LONG-TERM SURVIVAL IN REMISSION OF ADULT ACUTE MYELOID-LEUKEMIA (AML) PATIENTS
    RUVIDIC, R
    BOSKOVIC, D
    TOMIN, D
    ELEZOVIC, I
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1992, 34 (03): : 277 - 277